Why Is Hereditary Peripheral Neuropathy (IPN) in the News?
Researchers at the University of Michigan Medical School, through research published in Human Molecular Genetics, have clarified why only certain specific genetic mutations cause Hereditary Peripheral Neuropathy (IPN). This discovery could play a vital role in the future of Gene Therapy — a direct UPSC GS Paper 3 Science & Technology topic. Every such breakthrough is covered in depth in the UPSC Mentorship Program by Riyasat Ali Sir at Riyasat IAS Mentorship.
Hereditary Peripheral Neuropathy — Key Terms for UPSC Prelims
| Term | Explanation |
| IPN (Hereditary Peripheral Neuropathy) | Genetic nerve disorder affecting approximately 1 in 2,500 people — weakens nerves in hands and feet |
| ARS Enzyme | Aminoacyl-tRNA Synthetase — enzyme that makes protein in the body; mutations here cause IPN |
| Null Mutation | Faulty gene simply stops working but causes no active harm — like a broken light bulb |
| Dominant-Negative Mutation | Defective protein actively blocks the healthy protein from functioning — the “villain” mutation |
| Gene Silencing | Technology that specifically blocks a faulty mRNA or protein — key future treatment method |
| Budding Yeast | Simple organism used to test human gene mutations — same yeast used in bread/pizza |
| Gene Expression | Process: DNA -> mRNA -> Protein; obstruction at mRNA or protein level causes IPN |
5 Critical Facts — Hereditary Peripheral Neuropathy and Dominant-Negative Mutations
1. What Is IPN and Why Does It Matter?
IPN affects approximately 1 in every 2,500 people. The nerves in hands and feet become weak, causing difficulty walking, changes in foot shape, and inability to feel pain when injured. It is a genetic disorder caused by mutations in the ARS enzyme gene — the enzyme responsible for making proteins in the body. This topic falls directly under UPSC GS Paper 3 Science & Technology. Enrol in the Secure Prelims Program 2026 to master all such S&T topics for MCQs.
2. The Null Mutation vs Dominant-Negative Mutation — The Core Distinction
The key discovery is why only some mutations cause disease. Consider two light bulbs: if one breaks and stops glowing, the room still has light from the second — this is a Null Mutation (harmless stoppage). But in IPN, the broken bulb actively prevents the good bulb from glowing too. This is the Dominant-Negative Mutation — the defective protein blocks the healthy protein, causing disease. This analogy-based explanation is the kind of conceptual clarity the UPSC Mentorship Program at Riyasat IAS Mentorship builds for every aspirant.
3. Why Are Long Nerves Most Vulnerable?
The nerves in our arms and legs are extremely long. They require a constant supply of protein to function. When the Dominant-Negative protein blocks the healthy protein’s work, the supply to these long nerves drops first — which is why the hands and feet are the first organs affected in IPN.
4. The Role of Budding Yeast in the Research
Since direct experiments on humans are difficult, scientists used Budding Yeast — the same organism used in bread and pizza. They inserted human ARS genes into yeast and observed which mutations inhibited growth. This proved that Dominant-Negative mutations are the real cause of IPN. This is a brilliant example of using simple model organisms to understand complex human diseases — a recurring theme in UPSC Science & Technology. Explore related topics in the UPSC category at Riyasat IAS Mentorship.
5. Gene Silencing as the Future Treatment
The research opens the door to Gene Silencing — a technology that specifically blocks the villain mRNA or protein while allowing the healthy protein to function. Instead of trying to “fix” a faulty gene entirely, the treatment approach is to neutralise its negative effects. This represents a paradigm shift in genetic medicine and is a high-value UPSC Mains topic. The Essay Foundation Program at Riyasat IAS Mentorship trains you to write analytically on such cutting-edge science policy questions.
UPSC Relevance — Hereditary Peripheral Neuropathy and Gene Silencing
Prelims:
- IPN — definition, prevalence (1 in 2,500), affected body parts
- ARS enzyme — full form, role in protein synthesis
- Dominant-Negative mutation vs Null mutation — key distinction
- Gene Silencing — definition, mechanism, applications
- Budding Yeast as a model organism — why used in human disease research
- Gene Expression — DNA -> mRNA -> Protein pathway
Mains (GS Paper 3 — Science & Technology):
- Gene Therapy — current status, ethical concerns, future potential in India
- Dominant-Negative mutations — challenge to conventional treatment methods
- Role of model organisms (yeast) in advancing human medicine
- Gene Silencing (RNAi) — mechanism, applications, and policy implications
- Ethics of genetic intervention — UPSC Essay and GS Paper 4 angle
For structured preparation of Science & Technology topics like this, join the UPSC Mentorship Program by Riyasat Ali Sir. For comprehensive GS coverage, explore the Foundation Mentorship English course.
Practice Question (15 Marks, 250 Words):
“Evaluate the role of Gene Silencing technology in the treatment of genetic disorders. In the context of Hereditary Peripheral Neuropathy (IPN), discuss how Dominant-Negative mutations pose a challenge to conventional treatment methods.” (15 Marks, 250 Words)
Conclusion
The IPN research demonstrates that in future medicine, instead of trying to fix a faulty gene entirely, we may treat genetic diseases simply by blocking their negative effects. This represents a fundamental shift in how humanity approaches Gene Therapy. For complete command over such UPSC Science & Technology topics, join Riyasat IAS Mentorship. Apply for admission today.
Also Read:
- UPSC Mentorship Program — Riyasat Ali Sir
- Foundation Mentorship English
- Foundation Mentorship Hindi
- Secure Prelims Program 2026
- YATHARTH All India Mock Test Series
- Essay Foundation Program
- Current Affairs for UPSC
- Perfect UPSC Prelims Mock Test Strategy 2026
- 5 Signs You Need UPSC Prelims Mentorship
- FAQs — Riyasat IAS Mentorship
External References: